ANI PHARMACEUTICALS INC - Common Stock (ANIP)

CUSIP: 00182C103

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / Common Stock
Shares outstanding
22,278,088
Total 13F shares
1,286,937
Share change
+6,000
Total reported value
$25,805,000
Put/Call ratio
13%
Price per share
$20.08
Number of holders
28
Value change
+$120,000
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 00182C103?
CUSIP 00182C103 identifies ANIP - ANI PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q4 2013

As of 31 Dec 2013, ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,286,937 shares. The largest 10 holders included Healthcare Value Capital, LLC, BlackRock Institutional Trust Company, N.A., KENNEDY CAPITAL MANAGEMENT, INC., VANGUARD GROUP INC, MUTUAL OF AMERICA CAPITAL MANAGEMENT CORP, ESSEX INVESTMENT MANAGEMENT CO LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BRIDGEWAY CAPITAL MANAGEMENT INC, and US BANCORP \DE\. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2013 vs Q4 2025 Across Filers

Q4 2025 holders
283
Q4 2013 holders
28
Holder diff
-255
Investor Q4 2025 Shares Q4 2013 Shares Share Diff Share Chg % Q4 2025 Value $ Q4 2013 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .